Introduction
For on-line detection after high-performance liquid chromatography (HPLC), many methods of analysis are available, based on various physicochemical principles such as UV and fluorescence spectrometry and amperometry. In general, all these modes of detection are able to provide quantitative information for suitable compounds. Selectivity can be improved both by optimizing the chromatographic system and by selecting the optimum wavelength(s) or potential of the detection system used. Both parameters are determined by the molecular structure of the compound(s) to In a previous paper [1] , we described such a computerized cyclic voltammetric detection system in HPLC. Owing to the large background current, which is inherent in cyclic voltammetry using a glassy carbon electrode, the detection limit for quantitative analysis proved to be higher than that of voltammetric Etoposide and teniposide are known to be excreted in the urine in the form of the unchanged parent drug and the hydroxy acid derivative metabolite [3] . Both compounds differ significantly in concentration, polarity and lipophilicity.
For the determination of etoposide and teniposide, several HPLC systems have been reported, mostly using UV [4] [5] [6] [7] [8] and fluorescence detection [9, 10] . For the determination of the hydroxy acid metabolite, a method involving fluorescence detection was described by Strife et al. [4] .
As etoposide and teniposide possess a phenolic hydroxy group, oxidative electrochemical detection is also applicable [11] [12] [13] [14] . A routinely applicable method for the determination of the hydroxy acid metabolites of both drugs using amperometric detection has been described by Sinkule and Evans [12] . Holthuis [3] concluded that the quantitative HPLC of etoposide, using oxidative amperometry, provides more sensitive detection (absolute detection limit 250 pg) than UV (detection limit 100-500 ng/ml in plasma) and fluorescence methods (detection limit 50 ng/ml in plasma). [15] [16] [17] [18] [19] and fluorescence detection [20] [21] [22] [23] [24] [25] [26] . Anthracyclines possess both phenolic hydroxy groups, permitting oxidative electrochemical detection [27, 28] 
Adriamycin

Sample treatment
To determine teniposide in human urine, 50 ml of urine, after mixing with 5 ml of 0" phosphate buffer (pH 7"3), are extracted twice with 50 ml of DCE [3] . The [20] [21] [22] [23] [24] and adsorption chrornatography using a Celite column [25] , a loop column [27] or a syringe cartridge [26] . As the concentrations of the drug and its metabolite in urine are low in relation to the sensitivity of cyclic voltammetric detection, it is necessary to. extract a relatively large volume of urine.
To concentrate adriamycin and adriamycinol, 60 ml of human urine [buffered by 5 ml 0"1 phosphate buffer (pH 8"0)] are extracted twice with 100 ml of chloroformmethanol (9: 1) [23] . After To determine etoposide in human urine, 25 ml of urine, after mixing with 2"5 ml of 0"1 phosphate buffer (pH 7"3), are extracted twice with 25 ml of 1,2-dichloroethane (DCE) [13] . The organic layer is removed and evaporated under a stream of nitrogen at 30 C. The residue is dissolved by sonication in 1"00 ml of methanol. For determinations in the cyclic voltammetric mode, an aliquot of 10 btl is injected. In batchwise experiments using the static mercury drop electrode (SMDE), adriamycin and adriamycinol show an adsorption 'pre-peak' and a reduction peak in the cathodic (forward) scan and one oxidation peak in the anodic (backward) scan. The peak potentials in the cathodic and anodic scans of adriamycin and adriamycinol are -588 and -440 mV (n 4, SD 2 mV) and -547 and -440 mV (n 3, SD 3 mV), respectively.
As the peak potentials of the two compounds differ only slightly, separation techniques are needed for differentiation, in both stock solutions and biological samples.
In HPLC with cyclic voltammetric detection using the same electrodes and the same scan speed, both compounds show one reduction peak in the forward scan and one oxidation peak in the backward scan; the peak potentials of the cathodic and anodic scans of adriamycin and adriamycinol are -583 and -440 mV (n 5, SD 3 mV) and -538 and -440 mV (n 3, SD 3 mV), respectively.
Analysis of the urine extract demonstrate that both adriamycin and adriamycinol are detectable in the reductive cyclic voltammetric mode. Adriamycin shows one reduction peak (figure 4a), but probably the concentration of adriamycinol in the urine is too low to form a well defined peak in the cathodic scan (figure 4b). 
Conclusions
For qualitative analysis in particular, the computerized cyclic voltammetric detection system after HPLC described here has several promising properties compared with previously described amperometric systems at constant potential [11] [12] [13] [14] . The ultimate sensitivity for the analysis of biological samples has not yet been reached and needs to be optimized. As the.system is provided with an oxidative and reductive module, all kinds of electroactive compounds can be investigated.
The cyclic voltammetric system described has been applied to the identification ofetoposide and teniposide in urine samples using the oxidative mode and adriamycin and adriamycinol using the reductive mode.
In a previous study [1] 
